BackMedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Overview

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Current Assets

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s current assets is $60M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$59.74M
56.87% YoYΔ $21.66M vs prior year quarter

Peer trimmed avg / median

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Current Assets History

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) vs. peers: Current Assets Comparison

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War) (MTACU) FAQ

The latest current assets for MTACU is $60M as of June 2026. That compares with $38M in the prior-year period — up 56.9% year over year. Investors often review this figure alongside MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, MTACU's current assets moved from $38M to $60M — a 56.9% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MedTech Acquisition - Units (1 Ord Share Class A & 1/3 War)'s operating scale or balance-sheet position.

A current assets figure of $60M for MTACU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MTACU's current assets ($60M), review year-over-year change from $38M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.